MEYER COLIN JOHN (Chief Medical Officer) received a stock award from REATA PHARMACEUTICALS INC
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 7/10/2023ACC: 0001209191-23-041929
Officer· Chief Medical Officer
Since Jan 2019
+6K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
6K acquired
Non-Derivative Transactions1
Class A common stock
Direct
Shares
+6K
Price / share
—
Trade value
—
% of position
7.7%
7/6/2023
78.37K→84.37K
Total
Net shares
+6K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Class A common stock Direct | 7/6/2023 | A · Award | +6K | — | — | 7.7% | 78.37K | 84.37K |
| Total | +6K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported